A Probiotic and Kidney Function: What Six Months of Lactobacillus plantarum Did in 72 People With CKD

People living with chronic kidney disease (CKD) hear a lot about what to limit and much less about what might help. That makes any trial with a positive kidney result welcome, and it also makes it the kind of result I want to go through slowly before anyone changes their routine.

Six months, one strain, and a rise in kidney filtration
Researchers at Mansoura University in Egypt enrolled 72 adults with stage 3 or 4 CKD, which means moderate to severe loss of kidney function [1]. The researchers randomly assigned half of them to a daily capsule of the probiotic Lactobacillus plantarum and half to an identical placebo for six months. Neither the participants nor the research staff knew who was getting which, and all 72 people finished the study. Everyone stayed on standard kidney care, including a stable blood pressure regimen for those with high blood pressure.
The main measure was eGFR. That stands for estimated glomerular filtration rate, a calculation from a blood test that estimates how well the kidneys are filtering. In the probiotic group, median eGFR rose by 4.85 points over six months. The median is the middle value when everyone's results are put in order from lowest to highest. In the placebo group, median eGFR fell by 1.5 points. After adjusting for where each person started, the difference between groups was 7.72 points (95% confidence interval 5.63 to 9.82). A confidence interval is the range the true difference most plausibly falls within. A 24-hour urine test of kidney clearance also favored the probiotic group. Blood urea nitrogen fell in the probiotic group as well. Blood urea nitrogen is another waste marker that builds up when the kidneys filter less.
There was no clear difference between groups on the trial's other kidney measures. Protein in the urine increased in both groups, with no difference between them. Three people on placebo (8.6%) met the trial's definition of CKD progression compared with none on the probiotic, a difference that was not statistically significant. The researchers also measured indoxyl sulfate. Indoxyl sulfate is a waste product made by gut bacteria, and it builds up when the kidneys slow down. It did not differ between groups and was unrelated to the eGFR change, so the mechanism behind the result is still unknown. No side effects were reported.
Other probiotic and synbiotic trials in kidney disease
This trial is more positive than most of what came before it. A 2024 meta-analysis of 21 trials found that probiotics or synbiotics modestly lowered blood urea nitrogen and C-reactive protein in people with CKD [2]. A synbiotic is a probiotic combined with the fiber that feeds it, and C-reactive protein is a marker of inflammation. The authors called for larger studies because results varied between subgroups.
Two other trials found no benefit to kidney function. In the Australian SYNERGY II feasibility trial, 68 adults with stage 3 or 4 CKD took a synbiotic or a placebo for 12 months, and eGFR actually fell by about 3 points more in the synbiotic group [3]. A 2025 Bulgarian study in 50 people with stage 4 or 5 CKD found that a synbiotic lowered indoxyl sulfate over ten months, with no significant effect on kidney function after statistical correction [4]. That study was not randomized, so its result is weaker evidence than a randomized trial would give.
The Egyptian authors point to differences in strain, trial length, and disease stage to explain the mixed record [1]. That is a reasonable hypothesis. It is also true that their trial has important limits of its own: a single center, only 13 women, eGFR estimated from creatinine without a second marker like cystatin C, and no measurement of inflammation or the gut microbiome.
The gut-kidney connection in my clinical thinking
Much of my clinical work focuses on the gut, and the kidneys are closely connected to it. When the kidneys slow down, waste products from gut bacteria accumulate in the blood, and the gut environment itself changes [1]. In naturopathic practice, that two-way relationship is a good reason to pay attention to things like digestion, fiber intake, and bowel regularity in anyone with CKD, alongside the kidney-specific care they already receive.
I would also be careful with the leap from one trial to a shelf of products. This result applies to one specific strain in one population, and the researchers did not test a different strain or a multi-strain blend. I have no clinic protocol for probiotics in kidney disease, and I would not build one on a single trial.
Talking with your nephrologist about Lactobacillus plantarum
People with stage 3 or 4 CKD have a reason here for a conversation with their kidney team, and some details make that conversation more useful:
This was one strain, tested at one center, for six months. Until another group reproduces the result, it is an early and promising finding.
Your kidney team is already checking your labs. If you and your nephrologist decide to try a probiotic, keeping up regular lab work lets your nephrologist see whether anything changes.
Standard care stays in place. Every participant in this trial continued their usual kidney care, including stable blood pressure medication for those who needed it [1].
Some people were not included. The trial excluded people on immunosuppressive therapy, pregnant people, and anyone with structural gut disease or past gut surgery [1], so those groups need individual advice.
References
Saleh SE, Elnagar SSE, Fouda MA, Sayed-Ahmed N. Effects of probiotic supplementation on disease progression in patients with moderate to severe chronic kidney disease: a randomized controlled trial. Sci Rep. 2026;16(1). PMID: 42697907. doi:10.1038/s41598-026-67044-5. Original digest link: https://www.nature.com/articles/s41598-026-67044-5
Liu C, Yang L, Wei W, Fu P. Efficacy of probiotics/synbiotics supplementation in patients with chronic kidney disease: a systematic review and meta-analysis of randomized controlled trials. Front Nutr. 2024;11:1434613. PMID: 39166132. doi:10.3389/fnut.2024.1434613
McFarlane C, Krishnasamy R, Stanton T, et al. Synbiotics Easing Renal Failure by Improving Gut Microbiology II (SYNERGY II): a feasibility randomized controlled trial. Nutrients. 2021;13(12):4481. PMID: 34960037. doi:10.3390/nu13124481
Kuskunov T, Tilkiyan E, Zdravkova I, et al. The impact of a 10-month synbiotic intake on eGFR, uremic toxins, oxidative stress, and inflammatory markers in non-dialysis chronic kidney disease patients: a prospective, non-randomized, placebo-controlled study. Medicina (Kaunas). 2025;61(7):1199. PMID: 40731829. doi:10.3390/medicina61071199
This article is for education only and is not medical advice. If you have kidney disease, please talk with your nephrologist or primary care provider before starting any supplement, including probiotics.
If this resonates with what you're experiencing and you'd like to explore a naturopathic approach, book a consultation with our clinic.




Comments